How to Develop and Implement a National Drug Policy (Second Edition)
(2001; 96 pages) [French] [Spanish] View the PDF document
Table of Contents
View the documentContributors
View the documentAbbreviations and acronyms
View the documentPreface
Open this folder and view contentsPart I: How to develop and implement a national drug policy
Close this folderPart II: Key components of a national drug policy
Open this folder and view contents4. Selection of essential drugs
Open this folder and view contents5. Affordability
Open this folder and view contents6. Drug financing
Close this folder7. Supply systems
View the document7.1 Public or private? Or mixed?
View the document7.2 Drug procurement
View the document7.3 Local manufacture
View the document7.4 Distribution strategies
View the document7.5 Drug supply in emergency situations
Open this folder and view contents8. Drug regulation
Open this folder and view contents9. Rational use of drugs
Open this folder and view contents10. Research
Open this folder and view contents11. Human resources development
Open this folder and view contents12. Monitoring and evaluation
View the documentReferences
View the documentSelected WHO publications and documents of related interest
View the documentBack cover
 

7. Supply systems

Key policy issues

The fourth essential component of strategies to increase access to essential drugs is a reliable supply system. Key policy issues are:

• public-private mix in drug supply ad distribution systems;
• commitment to good pharmaceutical procurement practices in the public sector;
• publication of price information on raw materials and finished products;
• drug supply systems in acute emergencies;
• inventory control, prevention of theft and waste;
• disposal of unwanted or expired drugs.

to previous section
to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: October 7, 2014